Search over 86,000 Information Industry Mergers & Acquisitions:
Linden Capital Partners, acquired ProPharma Group
Like ProPharma Group
Education

Finance

Healthcare

Consumer

Human Capital

Media & Marketing

Software

Online & Mobile

Managed Services & IT Consulting

Private Equity

Online & Mobile
E-Commerce

Consumer
Miscellaneous

Media & Marketing
B2B Publishing and Information

Healthcare
Pharma IT

Medical Education

Pharma Business Services

Finance
Insurance

Education
Professional Training Services

Search Breadth
Narrower
Broader
By ProPharma Group
Healthcare

Private Equity

Healthcare
Pharma Business Services

By Linden Capital Partners
Healthcare

Media & Marketing

Private Equity

Media & Marketing
B2B Publishing and Information

Healthcare
Pharma Information

Pharma Business Services

Linden Capital Partners Competitor`s Deals
There are no acquistions that meet the criteria.
Try broadening Search Breadth
Search Breadth
Narrower
Broader
note: a single transaction may fall into multiple segments
view all transactions
All Segments
07/02/10 to 03/09/22
(41 results)
Transactions
Tombstones
Trends
Highlights
Overview
Geography
Company
Like ProPharma Group
- buyer to watch list
- seller to watch list
closed 10/3/2016 via Company Press Release
Linden Capital Partners, acquired ProPharma Group
synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer:
Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target:
ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/27/2021 via BNC Analysis
Paine Schwartz Partners, acquired Registrar Corp
synopsis: Paine Schwartz Partners, a private equity firm specializing in sustainable food chain investing, has acquired Registrar Corp from Bertram Capital. Registrar, headquartered in Hampton, VA, is a provider of U.S. Food and Drug Administration compliance software and services to food, medical device, drug, and cosmetic facilities all over the world.
buyer:
Paine Schwartz Partners
target: Registrar Corp
A global leader in sustainable food chain investing, Paine Schwartz Partners is a private equity firm focused exclusively on investment opportunities in the fast-growing, dynamic global food and agribusiness sectors. "
target parent:
Bertram Capital Management LLC
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities. Registrar Corp was founded in 2003 and has headquarters in Hampton, Virginia, USA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 3/6/2019 via Company Press Release
Advarra, acquired Kinetiq
synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent:
Linden Capital Partners
buyer: Advarra
target: Kinetiq
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent:
Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 1/23/2019 via Company Press Release
21 Partners, acquired ProductLife Group
synopsis: 21 Invest France has acquired ProductLife Group.ProductLife Group is an expert in regulatory affairs outsourced management and pharmacovigilance for the Healthcare and Life Sciences industries and more specifically for pharmaceutical laboratories.
buyer:
21 Partners
European-based 21 Partners uses reasonable efforts to obtain information from sources which it believes to be reliable, no representation or warranty is given that the information or opinions contained in this website are accurate, reliable or complete. "
target:
ProductLife Group
Based in France, ProductLife Group is the global leader in regulatory and safety services, consulting, and outsourcing solutions for the life sciences industry. ProductLife Group is built on a unique and functional platform-and-geographic-hub model.
price ($mm)
rev ($mm)
$28
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/21/2018 via BusinessWire
GHO Capital, acquired Validant
synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer:
GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target:
Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/30/2018 via PR Newswire
Premier Research Group, acquired Regulatory Professionals, Inc.
synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent:
ECI Partners
buyer: Premier Research Group
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target:
Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/13/2018 via Company Press Release
Bertram Capital Management LLC, acquired Registrar Corp
synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer:
Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target:
Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/3/2012 via BusinessWire
Dohmen Company, acquired BioSoteria, Inc.
synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer:
Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target:
BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/6/2017 via Company Press Release
The Access Group, acquired Alliance Life Sciences
synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Alliance Life Sciences. Alliance specializes in maximizing revenue and optimizing pricing for its customers. The firm offers global pricing analytic tools and data, outsourced contract and revenue management services and digital marketing operational services.
buyer parent:
Water Street Healthcare Partners
buyer: The Access Group
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target:
Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. Its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 4/14/2021 via Company Press Release
Sikich LLP, will acquire Process Stream
synopsis: Sikich will acquire the assets of Process Stream, a leader in digital transformation services for regulated industries, including life sciences and insurance. The acquisition of Process Stream advances Sikich's efforts to support businesses with end-to-end technology-enabled professional services.
buyer:
Sikich LLP
Sikich is a global company specializing in technology-enabled professional services. With more than 1,000 employees, Sikich draws on a diverse portfolio of technology solutions to deliver transformative digital strategies and ranks as one of the largest CPA firms in the United States. "
target:
Process Stream
Process Stream is a leader in digital transformation services for regulated industries, including life sciences and insurance. Process Stream specializes in quality management, IT compliance, and insurtech systems implementations and consulting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 3/9/2022 via Yahoo, Inc.
M&B Sciences Inc., acquired Clara Health
synopsis: M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology to increase access to clinical trials. Clara Health was created in 2015 to make it simple for patients to find clinical trials that fit them best.
buyer:
M&B Sciences Inc.
Established in 2016, M&B Sciences, Inc. is a California based, technology driven, minority owned Contract Research Organization that supports pharmaceutical and biotech sponsors. Their leadership has over 100 years of combined experience within the life sciences and healthcare industry. "
target:
Clara Health
Clinical trials are the longest and most expensive step in bringing a new treatment to market. Clara Health was created in 2015 from a collaboration with patient advocates to make it simple and approachable to find and connect to clinical trials that fit them best.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/16/2016 via PR Newswire
Indegene Lifesystems Pvt Ltd., acquired Wincere, Inc.
synopsis: Indegene, a global healthcare solutions provider, announced the acquisition of Wincere Inc. Wincere is a leading clinical data management and clinical and statistical programming solutions provider located on the West Coast in Silicon Valley, CA. Wincere is deeply engaged with clinical R&D needs of many emerging biopharma companies.
buyer:
Indegene Lifesystems Pvt Ltd.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. "
target:
Wincere, Inc.
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/1/2019 via BusinessWire
Validant, acquired DataRevive LLC
synopsis: Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.
buyer parent:
GHO Capital
buyer: Validant
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
target:
DataRevive LLC
DataRevive is a leading Regulatory Affairs consulting firm, providing high quality advice and expertise from the perspective of industry and regulators to support customers from across pharma and biotech as they seek to navigate the regulatory approval process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/17/2017 via Company Press Release
UL, Inc, acquired ChemADVISOR
synopsis: UL has acquired ChemADVISOR. ChemADVISOR is a leading provider of Environmental, Health, Safety, and Transportation information & regulatory compliance solutions to the global chemical-based manufacturing industry. The company offers database products, training programs and consulting services for handling hazardous materials.
buyer:
UL, Inc
UL fosters safe living and working conditions for people everywhere through the application of science to solve safety, security and sustainability challenges. The UL Mark engenders trust enabling the safe adoption of innovative new products and technologies. "
target:
ChemADVISOR
ChemADVISOR is a leading provider of Environmental, Health, Safety, and Transportation information & regulatory compliance solutions to the global chemical-based manufacturing industry. The company offers database products, training programs and consulting services for handling hazardous materials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/7/2021 via PR Newswire
TwoLabs, LLC, acquired Riparian, LLC
synopsis: Two Labs has acquired Riparian, a pharma consulting and SaaS company that helps manufacturers navigate pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs' suite of pharma services, allowing the company to provide greater insights around the financials associated with launching and managing a drug.
buyer parent:
GHO Capital
buyer: TwoLabs, LLC
buyer: TwoLabs, LLC
Two Labs is a leading pharmaceutical services company that provides a portfolio of market access, market intelligence, and commercialization services to pharmaceutical manufacturers. Two Labs has led 200+ new product launches and over 290 in-market projects from pre-launch to loss of exclusivity. "
target:
Riparian, LLC
Riparian is a pharma consulting, business process outsourcing, and SaaS company that helps manufacturers navigate government pricing regulations, reporting, strategies, and program operations. Riparian is a quickly growing, innovative company backed by a team of leading industry experts.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 7/2/2010 via BusinessWire
HMS, will acquire Allied Management Group
synopsis: HMS announced it has signed a definitive agreement to acquire privately-held Allied Management Group (AMG-SIU), a leading provider of fraud, waste, and abuse prevention and detection solutions for healthcare payors, in an all-cash transaction.
buyer:
HMS
(HMSY:$642.75)
HMS is the nation’s leader in coordination of benefits and program integrity services for payors of healthcare services. "
target:
Allied Management Group
Established in 1972, AMG-SIU provides audit and consulting services to both government and commercial healthcare payors. The company has developed a proprietary forensic claim editing system to analyze claim data for patterns of fraud, waste, and abuse.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 5/27/2020 via BNC Analysis
Readiness Associates, acquired Continuity Dynamics, Inc.
synopsis: Readiness Associates has acquired Continuity Dynamics, Inc., a company that has attained a leadership position with a focus on business continuity, disaster recovery, supply chain management, cybersecurity, risk, compliance, governance, public-private sector and the SMB market.
buyer:
Readiness Associates
As man-made and natural disasters continue to increase worldwide, Readiness Associates of Portland, Maine, is an essential full-service business continuity and emergency preparedness partner. "
target:
Continuity Dynamics, Inc.
Founded in 2006, Continuity Dynamics has attained a leadership position with a focus on business continuity, disaster recovery, supply chain management, cybersecurity, risk, compliance, governance, public-private sector and the SMB (small medium business) market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 4/21/2020 via BNC Analysis
Pacific Knowledge Systems, will acquire Pavilion Health
synopsis: Pacific Knowledge Systems (PKS), an Australian provider of clinical expert intelligence will acquire Pavilion Health Australia, an Australian specialist technology and consulting business focused on the healthcare industry. Pavilion Health provides cloud-based software products for medical coding and auditing.
buyer:
Pacific Knowledge Systems
(PKS.ASX:$6.12)
Pacific Knowledge Systems (PKS) is an Australian provider of clinical expert intelligence. Their RippleDown solution integrates patient data with a knowledge base that is managed by clinical domain experts, to deliver patient-specific reports, recommendation and alerts. "
target:
Pavilion Health
Pavilion Health is an Australian specialist technology and consulting business focused on the healthcare industry. Pavilion Health provides cloud-based software products for medical coding and auditing. Their consulting business provides audit and analysis services for coded data.
price ($mm)
$5.40
rev ($mm)
$3
EBITDA ($mm)
$1
EV / rev
1.9x
EV / EBITDA
5.1x
share
watch
bookmark
-
press release
closed 4/8/2020 via PR Newswire
TRC Healthcare, acquired Clinical IQ, LLC
synopsis: Therapeutic Research Center, LLC has acquired Clinical IQ and its training division CriticalPoint. Clinical IQ is the leading provider of consulting services in the areas of compounding and pharmacy information services, and CriticalPoint provides training programs and educational offerings focused on sterile and non-sterile compounding.
buyer parent:
Levine Leichtman Capital Partners Inc.
buyer: TRC Healthcare
buyer: TRC Healthcare
TRC is a provider of clinically referenced recommendations and education on drug therapy and medication management for pharmacists and other healthcare professionals. TRC also provides online continuing education programs for medication learning, competency, and compliance programs. "
target:
Clinical IQ, LLC
Clinical IQ is the leading provider of consulting services in the areas of compounding and pharmacy information services and solutions. CriticalPoint, the company's training division, is a premier provider of training programs and educational offerings focused on sterile and non-sterile compounding.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/30/2014 via BusinessWire
Weiser Mazars, LLP, acquired pmpm® Consulting Group Inc.
synopsis: WeiserMazars LLP, a leading accounting, tax and advisory services firm, has acquired pmpm® Consulting Group Inc., a national health care consulting firm specializing in providing managed care services including network development, contracting, credentialing, regulatory monitoring, oversight and compliance audits to payers and providers.
buyer parent:
Mazars Group
buyer: Weiser Mazars, LLP
buyer: Weiser Mazars, LLP
Since 1921, WeiserMazars LLP has provided a unique combination of foresight and experience when fulfilling client needs in accounting, tax and advisory services. Their team of over 100 partners and approximately 650 professionals is based out of eight U.S. offices, Israel and the Cayman Islands. "
target:
pmpm® Consulting Group Inc.
pmpm® Consulting Group Inc. is a national health care consulting firm specializing in providing managed care services including network development, contracting, credentialing, regulatory monitoring, oversight and compliance audits to payers and providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
Pages:
- buyer to watch list
- seller to watch list
closed 10/3/2016 via Company Press Release
Linden Capital Partners, acquired ProPharma Group
synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer:
Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target:
ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
- buyer to watch list
- seller to watch list
closed 7/9/2019 via BNC Analysis
Genstar Capital LLC, acquired Advarra
synopsis: Genstar Capital, a private equity firm focused on investments in financial services, healthcare, industrial technology, and software industries, has acquired Advarra, a leading provider of institutional review board, institutional biosafety committee, and research quality and compliance solutions that are critical to the drug development process.
buyer:
Genstar Capital LLC
target: Advarra
Genstar Capital is a leading private equity firm that actively invests in high quality companies. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. "
target parent:
Linden Capital Partners
target: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 3/6/2019 via Company Press Release
Advarra, acquired Kinetiq
synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent:
Linden Capital Partners
buyer: Advarra
target: Kinetiq
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent:
Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/3/2016 via Company Press Release
Linden Capital Partners, acquired ProPharma Group
synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer:
Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target:
ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
- buyer to watch list
- seller to watch list
Like ProPharma Group
read more
Pages:
read more
read more
read more
Geography
Matching Companies
Ticker: PBSV
Pharma-Bio Serv Inc.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
drill down
watch
Ticker: LSE:RPS
RPS Group plc
year
2019
rev ($mm)
$767.09
EBITDA ($mm)
$71.35
EBIT ($mm)
$44.78
Net Income ($mm)
$28.30
Employees
5556
drill down
watch
Ticker: OTCPK:MDCL
Medicine Man Technologies, Inc.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
drill down
watch
Ticker: PRSC
ModivCare Inc.
year
2021
rev ($mm)
$1,454.99
EBITDA ($mm)
$190.61
EBIT ($mm)
$155.98
Net Income ($mm)
$91.58
Employees
17500
drill down
watch
Ticker: DFM:AMANAT
Amanat Holdings PJSC
year
2019
rev ($mm)
$38.69
EBITDA ($mm)
($2.11)
EBIT ($mm)
($6.34)
Net Income ($mm)
$16.34
Employees
0
drill down
watch
Ticker: AIM:NSCI
NetScientific
year
2018
rev ($mm)
$0.45
EBITDA ($mm)
($10.78)
EBIT ($mm)
($11.09)
Net Income ($mm)
Employees
drill down
watch
Ticker: SEHK:575
Regent Pacific Group Limited
year
2020
rev ($mm)
EBITDA ($mm)
($5.71)
EBIT ($mm)
($33.93)
Net Income ($mm)
Employees
19
drill down
watch
Ticker: NYSE:OHI
Omega Healthcare Investors, Inc.
year
2020
rev ($mm)
$892.38
EBITDA ($mm)
$770.19
EBIT ($mm)
$454.45
Net Income ($mm)
$159.33
Employees
0
drill down
watch
Ticker: OB:CARA
Carasent
year
2021
rev ($mm)
$12.97
EBITDA ($mm)
$3.21
EBIT ($mm)
$1.99
Net Income ($mm)
Employees
51
drill down
watch
Ticker: CNSX:AUSA
Australis Capital Inc.
year
2019
rev ($mm)
$0.19
EBITDA ($mm)
($7.49)
EBIT ($mm)
($7.51)
Net Income ($mm)
$3.87
Employees
0
drill down
watch
Ticker: CSE:GHG
Global Hemp Group Inc.
year
2014
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.92)
Net Income ($mm)
Employees
drill down
watch